We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · October 11, 2021

Interactions Between Palbociclib and PPIs May Significantly Affect Clinical Outcome in Metastatic Breast Cancer

ESMO Open

 

Additional Info

Disclosure statements are available on the authors' profiles:

ESMO Open
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
ESMO Open 2021 Sep 09;6(5)100231, M Del Re, C Omarini, L Diodati, M Palleschi, I Meattini, S Crucitta, G Lorenzini, C Isca, A Fontana, L Livi, F Piacentini, S Fogli, U De Giorgi, R Danesi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading